Co-Authors
This is a "connection" page, showing publications co-authored by Garyphallia Poulakou and Konstantinos Syrigos.
Connection Strength
1.974
-
Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study. In Vivo. 2021 Jan-Feb; 35(1):653-661.
Score: 0.922
-
Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis. Atherosclerosis. 2021 08; 330:114-121.
Score: 0.238
-
Clinical examination practices and perceptions in the era of COVID-19. Expert Rev Respir Med. 2021 08; 15(8):967-971.
Score: 0.238
-
Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing. Thromb Res. 2021 08; 204:134-135.
Score: 0.238
-
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action. Br J Haematol. 2020 06; 189(5):846-847.
Score: 0.220
-
Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial. Infect Dis Ther. 2021 Dec; 10(4):2333-2351.
Score: 0.060
-
An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021 03 08; 10.
Score: 0.058